Recent News for DARE - Dare Bioscience, Inc.

Date Title
Jul 13 3 “Strong Buy” Penny Stocks That Could Deliver Massive Returns
Jun 17 Daré Bioscience launches late-stage study of lead candidate in bacterial inflammation
Jun 17 Daré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis
Jun 15 Daré Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive
Jun 4 Daré Bioscience Announces Participation in BIO Digital 2020
May 15 Edited Transcript of DARE earnings conference call or presentation 14-May-20 8:30pm GMT
May 15 Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2020 Results - Earnings Call Transcript
May 14 Dare Bioscience EPS beats by $0.15
May 14 Daré Bioscience Reports First Quarter 2020 Financial Results and Provides Company Update
May 11 Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
May 10 The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
May 7 Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020
May 2 Stocks To Watch: Jobs Report, Virtual Conferences And Blue Chips On Tap
May 2 Daré Bioscience files for 7.5M common shares
Apr 29 16 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Apr 28 Daré Bioscience CEO to Participate in Maxim Group’s Infectious Disease Virtual Conference
Apr 28 Wells softens view on Edwards Lifesciences in premarket analyst action
Apr 28 34 Stocks Moving in Tuesday's Pre-Market Session
Apr 27 13 Stocks Moving In Monday's After-Hours Session
Apr 23 Daré Bio launches stock purchase agreement for $15M
Apr 23 Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC
Apr 1 Edited Transcript of DARE earnings conference call or presentation 30-Mar-20 8:30pm GMT
Apr 1 Daré Bioscience Receives Third Notice of Award from National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the Development of Ovaprene®
Mar 30 Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q4 2019 Results - Earnings Call Transcript
Mar 30 Dare Bioscience Inc to Host Earnings Call

Back to the Main DARE Page...